Activities of RNMOT |
About the work of the Russian Scientific Medical Society of Internal Medicine during the period of coronavirus pandemic
|
7-8 |
Report on work performed by Expert council «Actual aspects of iron deficiency in the Russian Federation»
|
10-19 |
INVITATION TO DISCUSSION |
Zaitzev A.A.
COVID-19: controversial aspects of patients’ curation
|
20-24 |
Vorobyev P.A., Momot A.P., Zaitsev A.A., Elykomov V.A., Sychev D.A., Krasnova L.S., Vorobyev A.P., Vasiliev S.A., Vorobyeva N.A.
Disseminated intravascular blood coagulation syndrome in case of COVID-19 infection
|
25-34 |
Zayratyants O.V., Malyavin A.G., Samsonova M.V., Chernyaev A.L., Mishnev O.D., Mikhaleva L.M., Krupnov N.M., Kalinin D.V.
Pathomorphological changes in lungs in case of COVID-19: clinical and therapeutic parallels
|
35-46 |
Original articles |
Kokorin V.A., Manevich T.M., Dubov A.A., Efremkin I.V., Kosmynin V.S., Onuchina Yu.S., Darmaeva I.P., Zolozov S.V., Lobachev E.V., Mandrygina E.L., Sharashkina N.V., Shirin D.A., Naumov A.V., Kotovskaya Yu.V., Milto A.S., Tkacheva O.N.
First results of management of patients with bilateral pneumonia caused by a confirmed or probable new COVID-19 coronavirus infection in the reprofiled department of The Russian Clinical and Research Center of Gerontology
|
47-55 |
Maksimov V.A., Tkacheva O.N., Strazhesko I.D., Torshin I.Yu., Gromova O.A., Chuchalin A.G., Lazebnik L.B.
Human placenta hydrolysate as a drug to reduces markers of inflammation in patients with severe COVID-19
|
56-68 |
Dolbin S.S., Adasheva T.V., Samorukova E.I., Malyavin A.G., Li V.V., Vysotskaya N.V., Zadionchenko V.S.
Stratification of cardiovascular risk in patients with chronic obstructive pulmonary disease
|
69-77 |
Koliev V.I., Sarapulova I.Y., Kravchenko V.N., Shaposhnik I.I., Ryabova L.V.
Features of the early detection of heart failure in chronic obstructive pulmonary disease
|
78-84 |
Korneeva N.V., Khelimskaya I.V., Kim Ch.O., An A.S., Schennikov E.L., Belun I.F., Praslova N.Yu.
Analysis of smoking behavior in patients with chronic obstructive pulmonary disease
|
86-92 |
Statsenko M.E., Lopushkova Yu.Е., Derevyanchenko M.V., Urlapova E.I.
The effect of meldonium on arterial stiffness and the level of C-reactive protein in complex therapy of chronic heart failure and chronic obstructive pulmonary disease
|
94-101 |
Miroshnichenko A.I., Petrova A.A., Ivanov K.M., Krasikov S.I.
The state of lipid peroxidation processes and the antioxidant defense system in obstructive sleep breathing disorders
|
102-106 |
Traktirskaya O.A., Adasheva T.V., Zadionchenko V.S., Pavlov S.V., Boyko A.N., Popova E.V.
The state of microcirculation in patients with relapsing-remitting multiple sclerosis
|
108-116 |
REVIEWS |
Babak S.L., Gorbunova M.V., Malyavin A.G.
Algorithm of oxygene therapy and noninvasive ventilation in COVID-19 patients
|
117-124 |
Malyavin A.G.
The logical choice of inhalation device in patients with bronchial asthma and chronic obstructive pulmonary disease
|
125-131 |
Golousenko I.Yu., Malyavin A.G.
Dermatosis associated with somatic pathology
|
132-139 |
Polyakova I.N., Stryuk R.I.
Acute respiratory viral disorders in pregnant women: what general practice physician should know
|
140-146 |
Khripunova A.A., Boeva O.I., Dzhanibekova A.R., Krasnov A.Yu., Khripunova I.G.
Epidemiology and diagnostics of familial hypercholesterolemia in the Russian population
|
147-156 |
Kotova D.P., Shemenkova V.S.
Algorithms of antithrombotic therapy of patients in the perioperative period: what should a clinican knows?
|
157-162 |
GUIDELINES FOR PRACTITIONERS |
Roitberg G.E., Dorosh Zh.V.
Atypical pneumonia in October 2019: a case from everyday practice
|
163-169 |
Shchekina S.A., Kunyaeva T.A., Selezneva N.M., Rebrushkin A.V.
Clinical case of Wegener’s granulomatosis in a 68-year-old female patient
|
170-173 |
ACTUAL ISSUES OF PHARMACOTHERAPY |
Malyavin A.G.
Summary of the possibilities of using Likopid medicine in pulmonological and phthisiatric practice
|
174-186 |
Schulkin A.V., Filimonova A.A.
Role of free radical oxidation, hypoxia and their correction in COVID-19 pathogenesis
|
187-194 |
Malyavin A.G., Kozulina I.E., Sharapova Yu.A.
Five molecules for targeted biological therapy of severe bronchial asthma: realities and perspectives
|
195-205 |
Vorobyova N.M., Tkacheva O.N.
Rebamipide as a remedy for prevention and treatment of gastro- and enteropathy related to antiplatelets, anticoagulants and NSAIDs therapy
|
206-220 |